Publications by authors named "Michelle Mahoney"

Claim this Profile
M
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
Gina L Mazza, Molly M Petersen, Brenda Ginos, Blake T Langlais, Narre Heon, Michelle R Mahoney

Qual Life Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
Gina L Mazza, Molly M Petersen, Brenda Ginos, Blake T Langlais, Narre Heon, Michelle R Mahoney

Qual Life Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Ethan Basch, Claus Becker, Lauren J Rogak, Deborah Schrag, Bryce B Reeve, Michelle R Mahoney

Clin Trials· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical Trials.
Jennifer G Le-Rademacher, Shauna Hillman, Elizabeth Storrick, Michelle R Mahoney, Peter F Thall

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
Oghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, Chih-Yang Wang, Ace J Hatch, Michelle R Mahoney

JCI Insight· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib for Advanced and Refractory Desmoid Tumors.
Mrinal M Gounder, Michelle R Mahoney, Brian A Van Tine, Vinod Ravi, Steven Attia

N Engl J Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Sandra P D'Angelo, Michelle R Mahoney, Brian A Van Tine, James Atkins, Mohammed M Milhem

Lancet Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance).
Nadine J McCleary, Joleen Hubbard, Michelle R Mahoney, Jeffrey A Meyerhardt, Daniel Sargent

J Geriatr Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chanzyme TRPM7 Mediates the Ca Influx Essential for Lipopolysaccharide-Induced Toll-Like Receptor 4 Endocytosis and Macrophage Activation.
Michael S Schappe, Kalina Szteyn, Marta E Stremska, Suresh K Mendu, Taylor K Downs, Michelle A Mahoney

Immunity· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
Robert R McWilliams, Nathan R Foster, Michelle R Mahoney, Thomas C Smyrk, Joseph A Murray

Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).
Joleen M Hubbard, Michelle R Mahoney, William S Loui, Lewis R Roberts, Thomas C Smyrk

Target Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
Scott Okuno, Ivy Petersen, Thomas Shives, Michelle Mahoney, Michael Haddock

Am J Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance).
Frank A Sinicrope, Michelle R Mahoney, Harry H Yoon, Thomas C Smyrk, Stephen N Thibodeau

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Ni-Catalyzed C-H Functionalization in the Formation of a Complex Heterocycle: Synthesis of the Potent JAK2 Inhibitor BMS-911543.
Monica A Fitzgerald, Omid Soltani, Carolyn Wei, Dimitri Skliar, Bin Zheng, Michelle Mahoney

J Org Chem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma.
Sandra P D' Angelo, Michelle R Mahoney, Brian A Van Tine, Douglas R Adkins, Maria T Grosse Perdekamp

Cancer Chemother Pharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Frank A Sinicrope, Qian Shi, Thomas C Smyrk, Stephen N Thibodeau, Rodrigo Dienstmann, Michelle Mahoney

Gastroenterology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of the 6-azaindole containing HIV-1 attachment inhibitor pro-drug, BMS-663068.
Ke Chen, Christina Risatti, Michael Bultman, Maxime Soumeillant, James Simpson, Michelle Mahoney

J Org Chem· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147.
Wilson I Gonsalves, Michelle R Mahoney, Daniel J Sargent, Garth D Nelson, Steven R Alberts

J Natl Cancer Inst· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.
Jocelin Huang, Suresh G Nair, Michelle R Mahoney, Garth D Nelson, Anthony F Shields

Clin Colorectal Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).
Harry H Yoon, David Tougeron, Qian Shi, Steven R Alberts, Michelle R Mahoney

Clin Cancer Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of amphiphilic 6-carboxypullulan ethers.
Junia M Pereira, Michelle Mahoney, Kevin J Edgar

Carbohydr Polym· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.
Frank A Sinicrope, Michelle R Mahoney, Thomas C Smyrk, Stephen N Thibodeau, Robert S Warren

J Clin Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current use and surgical efficacy of laparoscopic colectomy in colon cancer.
Robert P Sticca, Steven R Alberts, Michelle R Mahoney, Daniel J Sargent, Lisa M Finstuen

J Am Coll Surg· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.
Philip A Philip, Michelle R Mahoney, Kyle D Holen, Donald W Northfelt, Henry C Pitot

Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.
Steven R Alberts, Daniel J Sargent, Suresh Nair, Michelle R Mahoney, Margaret Mooney

JAMA· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis